Barr cleared for Allegra D generic
This article was originally published in The Tan Sheet
Executive Summary
Firm's ANDA for Aventis' Allegra D was tentatively approved July 1; Barr believes it was first to file an ANDA and Paragraph IV certification on certain Allegra D patents. Mylan and Impax also hold tentative ANDA approval on Allegra D...